seizure resistance and reduced neuronal excitotoxicity in mice lacking the Ca v 2.3 E/R-type voltage-gated calcium channel. . Voltage-gated calcium channels are key components in the etiology and pathogenesis of epilepsies. Former studies mainly focused on P/Q-type Ca v 2.1 and T-type Ca v 3.2 Ca 2ϩ channels involved in absence epileptogenesis, but recent findings also point to an intriguing role of the Ca v 2.3 E/R-type Ca 2ϩ channel in ictogenesis and seizure propagation. Based on the observation that Ca v 2.3 is thought to induce plateau potentials in CA1 pyramidal cells, which can trigger epileptiform activity, our recent investigation revealed reduced PTZ-seizure susceptibility and altered seizure architecture in Ca v 2.3 Ϫ/Ϫ mice compared with controls.
I N T R O D U C T I O N
Voltage-gated calcium channels (VGCCs) are of tremendous importance in etiology and pathogenesis of various forms of epilepsies capable of modulating seizure initiation, propagation, termination, and kindling (Khosravani and Zamponi 2006; McKeown et al. 2006; Remy and Beck 2006) . Interestingly, only a restricted number of these channels has been directly associated with epileptic disorders in humans and animal models so far, including Ca v 2.1 and Ca v 3.2 (Khosravani and Zamponi 2006) . Recently, however, it turned out that the Ca v 2.3 E/R-type VGCC also harbors a potential proictogenic/proepileptogenic capacity that has been underestimated for a long time (Tai et al. 2006; Weiergräber et al. 2006a,b) . Being resistant to most other VGCC antagonists, such as dihydropyridines (DHPs), -conotoxin GVIA, -conotoxin MVIIC, and -agatoxin IVA (Catterall et al. 2005) , Ca v 2.3 E/R-type VGCCs exhibit a significant sensitivity toward Ni 2ϩ (IC 50 ϭ 30 M) (Schneider et al. 1994; Tottene et al. 2000) and the tarantula toxin SNX-482 (IC 50 ϭ 15-30 nM) (Newcomb et al. 1998) .
Recent findings in hippocampal CA1 neurons elucidated that R-type channels can trigger epileptiform activity by contributing to plateau potentials after cholinergic stimulation (Kuzmiski et al. 2005; Tai et al. 2006) . Muscarinic activation by M 1 /M 3cholinergic receptors was shown to enhance both Ca v 2.3 and R-type currents (Bannister et al. 2004; Melliti et al. 2000; Meza et al. 1999) , but not T-type Ca 2ϩ currents in rat hippocampal CA1 pyramidal neurons after P/Q-, N-, and L-type Ca 2ϩ currents were selectively blocked (Tai et al. 2006 ). This muscarinic stimulation (e.g., using carbachol) is capable of inducing plateau potentials on the cellular level by G␣ q/11 and protein kinase C (PKC) but also theta bursts in extracellular recordings from the CA1 region (Tai et al. 2006 ). The epileptogenic capacity of Ca v 2.3 in triggering hippocampal seizure activity is further supported by the observation that M 1 receptor knockout mice exhibit decreased seizure susceptibility after pilocarpine administration (Hamilton et al. 1997) .
Interestingly, R-type Ca 2ϩ channels exhibit a complex functional modulation based on internal Ca 2ϩ levels and PKCmediated phosphorylation. At lower cytosolic Ca 2ϩ concentrations, a positive feedback mechanism, which includes activation through PKC, slows down inactivation and speeds up recovery from short-term inactivation (Klöckner et al. 2004; Leroy et al. 2003) . Also, the pattern of Ca v 2.3 splice variant distribution in different brain regions is important for neuronal mechanisms underlying ictogenesis, seizure propagation, but also neuroprotection (Weiergräber et al. 2006a ). In concordance with these findings, recent electroencephalographic characterization of Ca v 2.3-inactivated mice exhibited no indications of spontaneous epileptiform graphoelements. In contrast, pentylenetetrazol (PTZ)-seizure susceptibility was reduced and seizure architecture exhibited appreciable alterations in Ca v 2.3 Ϫ/Ϫ mice compared with controls, supporting a proconvulsive capacity of Ca v 2.3 (Weiergräber et al. 2006a,b) .
Given its contribution to plateau potential generation in CA1 hippocampal neurons capable of triggering epileptiform activity, we investigated the role of Ca v 2.3 in hippocampal seizure susceptibility and seizure architecture by means of electroencephalography (EEG) and behavioral analysis in both Ca v 2.3 ϩ/ϩ and Ca v 2.3 Ϫ/Ϫ mice using kainic acid (KA) and N-methyl-D-aspartate (NMDA). We further performed histo-logical analysis to unravel differences in hippocampal excitotoxicity. Our results demonstrate that Ca v 2.3 Ϫ/Ϫ mice exhibit a pronounced resistance to hippocampal seizures and reduced excitotoxicity.
M E T H O D S

Study animals
Generation of the Ca v 2.3 null mutant, which was backcrossed into C57Bl/6, was previously described in detail (Pereverzev et al. 2002; Weiergräber et al. 2006a) . Ca v 2.3-deficient and control mice (with identical genetic backgrounds) from both genders were used in this study. Mice were housed in makrolon cages type II and maintained on a conventional 12-h light/dark cycle with food and water available without restriction. All animal experimentation was approved by the local institutional committee on animal care.
Hippocampal seizure-susceptibility testing: experimental design
Kainic acid (KA) and NMDA (both from Sigma, Munich, Germany) were freshly dissolved in physiological 0.9% NaCl before injection. Each animal was isolated for Ն30 min before administration of convulsants.
Kainic acid-induced hippocampal seizures
The non-NMDA receptor agonist KA was administered intraperitoneally (ip) to Ca v 2.3 ϩ/ϩ (n ϭ 18; 24.0 Ϯ 0.7 g; 16.1 Ϯ 0.8 wk) and Ca v 2.3 Ϫ/Ϫ mice (n ϭ 18; 25.5 Ϯ 1.1 g; 22.9 Ϯ 1.5 wk) at a dose of 30 mg/kg. Genders were exactly balanced with nine ( and nine & in each study group. After injection animals were immediately placed back into their home cage, observed, and videomonitored for 2 h. Administration of KA causes a well-characterized hippocampal seizure syndrome that was analyzed according to a slightly modified seizure score from Baran et al. 1994 : stage 1, no behavioral change; stage 2, facial clonus; stage 3, forlimb clonus; stage 4, rearing; stage 5, falling; stage 6, status epilepticus; stage 7a, jumping, tonic seizure Ͻ30 s; stage 7b, jumping, tonic seizure 30 -60 s; stage 8, maximum generalized seizure activity, respiratory arrest, and death.
NMDA-induced hippocampal seizures
Seizures were induced by ip administration of NMDA at a dose of 150 mg/kg. Twenty Ca v 2.3 ϩ/ϩ (21.7 Ϯ 0.8 g; 18.1 Ϯ 1.9 wk) and 20 Ca v 2.3 Ϫ/Ϫ (23.4 Ϯ 0.9 g; 16.4 Ϯ 1.2 wk) mice were used in this study and videomonitored for 2 h after injection. Genders were again balanced with seven ( and 13 & in each population. In NMDAtreated mice, seizures developed through a sequence of paroxysmal scratching, hypermotility and circling, tonic-clonic convulsions, and, occasionally, death. The following semiquantitative scale was used for the examination of seizure severity slightly modified according to Marganella et al. 2005 : stage 0, no response; stage 1, excessive grooming and paroxysmal scratching; stage 2, mild hypermotility; stage 3, extensive hypermotility and circling; stage 4, forepaw clonus and tail hypertonus; stage 5, generalized tonic-clonic convulsions; stage 6, status epilepticus; stage 7, death.
Collecting data for seizure-susceptibility analysis
Latencies were calculated as the time from injection of KA and NMDA to the first observation of the individual seizure phase. If animals did not undergo a specific seizure phase during the observation period, it was assigned a latency of 120 min for both substances. In addition, the frequencies with which an animal entered the various phases during the observation period were also counted. Time points and frequencies were noted on-line and rechecked using mouse video recordings.
Telemetric surface and intrahippocampal EEG recordings
Both TA10ETA-F20 and TL11M2-F20-EET transmitters (DSI, St. Paul, MN) were used for electrocorticographic and deep intrahippocampal EEG recordings in Ca v 2.3 ϩ/ϩ and Ca v 2.3 Ϫ/Ϫ mice. The telemetry system, implantation procedure, and postoperative treatment were previously described in detail (Weiergräber et al. 2005) . SURFACE ELECTRODE IMPLANTATION (ELECTROCORTICOGRAM, ECOG). Epidural leads were positioned at the border of primary to secondary motor cortex (M 1 /M 2 ) at the following stereotaxic coordinates: (ϩ)-lead, bregma ϩ1 mm, lateral of bregma 1 mm (left hemisphere); (Ϫ)-lead, bregma ϩ1 mm, lateral of bregma 1 mm (right hemisphere) and fixed at the neurocranium using dental cement.
INTRACEREBRAL ELECTRODE IMPLANTATION. For deep intrahippocampal recordings targeting the CA1 region electrodes were positioned as follows: (ϩ)-lead, bregma Ϫ2 mm, lateral of bregma 1.5 mm (left hemisphere), dorsoventral (depth) 1.3 mm; (Ϫ)-lead, bregma Ϫ2 mm, lateral of bregma 1.5 mm (right hemisphere); dorsoventral 1.3 mm. In total, nine Ca v 2.3 ϩ/ϩ (28.0 Ϯ 0.8 g, 17.5 Ϯ 1.7 wk, all () and nine Ca v 2.3 Ϫ/Ϫ mice (28.8 Ϯ 1.2 g, 20.1 Ϯ 1.6 wk, all () were analyzed that did not belong to the behavioral study groups. After recovery (7-10 days post-implantation) animals were administered KA at 10 mg/kg ip (n ϭ 3 for each genotype) and 30 mg/kg ip (n ϭ 6 for each genotype) and EEGs recorded for Ն2 h. In addition, daily recordings (minimum 1 h) were carried out in controls for 1 wk after injection.
Brain histology and histochemistry
Brains from KA (30 mg/kg ip) treated Ca v 2.3 ϩ/ϩ (n ϭ 3, all () and Ca v 2.3 Ϫ/Ϫ (n ϭ 3, all () mice were exstirpated 7 days post-injection and fixed in 4% formaldehyde. Hippocampal sections (bregma: Ϫ1.7 mm) were analyzed for KA-induced excitotoxic effects using standard hematoxylin-eosin (HE) and Nissl-staining.
Statistical analysis
To acquire and analyze EEG data, the Dataquest A.R.T. 3.1 software (DSI) was used. EEG recordings were obtained as outlined earlier. In addition long-term deep intrahippocampal EEG recordings (Ͼ24 h) were performed 7-10 days post-surgery. EEG activity was sampled at 1,000 Hz with no filter cutoff. Absolute power spectrum density (PSD, mV 2 /Hz) was calculated from 5-min segments using the periodogram function (FFT based with Hanning windowing method). Frequency ranges were defined as follows: sub-␦ (0 -1 Hz), ␦ (1-4 Hz), (4 -8 Hz), ␣ (8 -12 Hz), ␤ (12-32 Hz), ␥ (32-50 Hz). All data were calculated and displayed as the means Ϯ SE. Statistical comparison of categorical variables (e.g., occurrence of seizure stages, lethality) was performed using Fisher's exact probability test (twotailed), whereas continuous variables (e.g., seizure latencies, frequencies) were analyzed using the parametric Student's t-test, considering P Ͻ 0.05 as significant.
R E S U L T S
Hippocampal KA seizure susceptibility in Ca v 2.3-deficient and control mice
Analysis of Ca v 2.3 ϩ/ϩ and Ca v 2.3 Ϫ/Ϫ mice after KA administration revealed a complex alteration in behavioral seizure architecture with Ca v 2.3-deficient animals exhibiting pro-nounced seizure resistance (Table 1) . The most prominent observation is that a significantly higher number of control mice exhibit severe status epilepticus (56.3 vs. 0%; P ϭ 0.0017) and maximum generalized seizure activity associated with death (50 vs. 0%; P ϭ 0.0010) compared with Ca v 2.3deficient animals. This is concomitant with a significant reduction in stage 6 and stage 8 frequency and increase in latency for controls (Table 1A ). Furthermore, stage 5 latency was significantly increased but frequency nonsignificantly reduced in Ca v 2.3 Ϫ/Ϫ mice. No difference was observed between the two genotypes for both generalized seizure stages (stages 7a and 7b) characterized by jumping and tonic events except an increase in stage 7a frequency in Ca v 2.3 Ϫ/Ϫ mice. Interestingly, some parameters of lower seizure severity (e.g., stage 2 and 3 frequency) were significantly increased in Ca v 2.3 Ϫ/Ϫ mice similar to results obtained previously (Weiergräber et al. 2006a ). However, similar to our prior studies using PTZ and 4-AP, KA-induced seizure severity is clearly reduced in Ca v 2.3-deficient mice (Table 1A ). In particular, results from stages 6 and 8 point to a functional role of Ca v 2.3 in seizure perturbation and generalization.
Parameters known to affect seizure susceptibility (e.g., age and body weight) were approximated at the best possible rate and genders were exactly balanced. Although KA but not NMDA study groups differed significantly in age (P ϭ 0.0003 and P ϭ 0.4547, respectively) there is no information given in the literature that such minor differences (6 -7 wk) cause significant alterations in seizure susceptibility. We strictly avoided to use inappropriately aged animals (juvenile Ͻ3 wk and old mice Ͼ1 yr). In our study KA-induced lethality was slightly higher in male compared with female controls (55.6 vs. 44.4%), similar to results obtained in rats (Mejias-Aponte et al. 2002) , although not reaching level of significance.
Hippocampal NMDA seizure susceptibility in Ca v 2.3deficient and control mice NMDA seizure analysis of 20 controls and 20 Ca v 2.3 Ϫ/Ϫ mice revealed a tendency similar to that observed for KA. Again, Ca v 2.3 Ϫ/Ϫ mice exhibited reduced seizure susceptibility, particularly to stages of higher seizure severity. The survival rate of Ca v 2.3-deficient mice was 90%, but only 60% in control animals not reaching the level of significance (P ϭ 0.0648). In addition, occurrence of generalized tonic-clonic convulsions and status epilepticus are also reduced in Ca v 2.3 Ϫ/Ϫ mice close to the level of significance (Table 1B) . Latency data for stages 5-7 are also increased in knockouts, although not significantly. It is also worthwhile to note that lethality in female Ca v 2.3 ϩ/ϩ mice was higher compared with males (46.2 vs. 28.6%), although not significant (P ϭ 0.6424).
Electrocorticogram (ECoG) and deep intracerebral EEG recordings after KA administration
Analysis of deep intrahippocampal long-term EEG recordings from the CA1 region of both Ca v 2.3 ϩ/ϩ and Ca v 2.3 Ϫ/Ϫ mice did not reveal any spontaneous ictal-like discharges that are indicative of limbic seizure activity (Fig. 1, A and B) . Because seizuresusceptibility studies (see above) were carried out at 30 mg/kg to obtain behavioral phenomena, subsequent EEG recordings were also performed at that dosage (Figs. 1, C-F and 2, A and B). Initially, pilot studies were carried out to validate that intrahippocampal EEG recordings can be reliably distinguished from cortical EEG activity after KA administration by simultaneous recordings from the CA1 and M1/M2 region using a TL11M2-F20-EET transmitter (Fig. 2B ). Unlike PTZ-induced seizure activity (Weiergräber et al. 2006a ), we did not observe any indications of altered KA-induced seizure architecture. Analysis of ictal episode duration in Ca v 2.3 ϩ/ϩ (7.1 Ϯ 2.3 min, n ϭ 6) and Ca v 2.3 Ϫ/Ϫ mice (6.5 Ϯ 1.6 min, P ϭ 0.8174, n ϭ 6) did not reveal any difference (Fig. 3A) and similar results were obtained for interictal phases (3.9 Ϯ 0.4 vs. 2.5 Ϯ 0.7 min, P ϭ 0.0868, n ϭ 6, Fig. 3B ). As depicted in Fig. 2, A and B both controls and Ca v 2.3-deficient mice exhibit contiguous spike and spike-wave activity throughout the 2-h observation period. This epileptic activity is within the delta-and theta-wave range (1-8 Hz), as confirmed by power spectrum analysis. At 30 and 10 mg/kg KA, no major differences in hippocampal seizure activity could be detected between both genotypes (Figs. 2 and 3 ). PSD analysis of ictal episodes (30 s) did not reveal any differences between both genotypes (Fig. 3C) . Although analysis of the entire 2-h EEG recording period after KA (30 mg/kg) administration revealed a more rapid onset of theta, delta, and particularly subdelta activity in controls compared with Ca v 2.3 Ϫ/Ϫ mice (Fig. 3D ), these differences did not reach the level of significance. In addition, latency to first onset of exacerbating EEG seizure activity did not differ significantly between Ca v 2.3 ϩ/ϩ and Ca v 2.3 Ϫ/Ϫ mice (7.2 Ϯ 1.6 vs. 7.0 Ϯ 2.7 min; P ϭ 0.9351) and no alteration in latencies to peak PSD values for the individual frequency ranges could be detected (Fig. 3E ). Thus hippocampal EEG seizure activity does not vary between Ca v 2.3 ϩ/ϩ and Ca v 2.3 Ϫ/Ϫ mice at 30 mg/kg KA. Even at 10 mg/kg mice from both genders appeared to be behaviorally normal, although exhibiting a hippocampal status (Fig. 2, C and D) . Thus both dosages turned out to be far beyond hippocampal seizure threshold in either genotype.
However, seizure generalization including motoric components (e.g., clonic events and status epilepticus) could be induced only with higher doses (30 mg/kg). Thus the pronounced KA-induced seizure resistance in Ca v 2.3 Ϫ/Ϫ mice points not only to an ictogenic potential of Ca v 2.3 but also to its role in seizure spreading and generalization.
Kainic acid-induced hippocampal excitotoxicity in Ca v 2.3 ϩ/ϩ and Ca v 2.3 Ϫ/Ϫ mice
To unravel the role of Ca v 2.3 in modulating excitotoxic cell death we performed histochemical analysis of brains derived from Ca v 2.3 Ϫ/Ϫ and Ca v 2.3 ϩ/ϩ mice 1 wk after ip administration of KA (30 mg/kg). In rodents, peripheral injections of KA result in recurrent seizures and subsequent degeneration of selected populations of neurons within the hippocampus. EEG recordings for a 1-wk period after KA administration revealed that, although decreasing, hippocampal seizure activity still persists (Fig. 1, C-F) . This leads to a time-dependent, hyperexcitability-mediated neuronal degeneration within the hippocampus, particularly CA3, paving the way for further excitotoxic damage. Both Nissl and HE staining exhibit prominent neuronal cell loss and neurodegeneration in the CA3 region of Ca v 2.3 ϩ/ϩ mice but not in Ca v 2.3-deficient animals (Fig. 4,  A-D) . In Ca v 2.3 ϩ/ϩ mice, only 11% of neurons within the stratum pyramidale (CA3) exhibit an intact morphology after Nissl or HE staining (Fig. 4C ). However in Ca v 2.3 Ϫ/Ϫ mice, 89 and 90% of neurons reveal an intact cell shape after Nissl and HE staining, respectively. In addition, the number of countable (intact and degenerating) cells is reduced by 13.4% in Ca v 2.3 ϩ/ϩ mice compared with Ca v 2.3 Ϫ/Ϫ mice. Note also the fading appearance of condensed chromatin in Ca v 2.3 ϩ/ϩ CA3 pyramidal neurons compared with Ca v 2.3-deficient animals (Fig. 4C, two left panels vs. right panels) . As hippocampal seizure activity emerged to be similar in both genotypes at 30 mg/kg, reduced excitotoxicity in Ca v 2.3 Ϫ/Ϫ mice also points to an intriguing role of Ca v 2.3 in neuronal cell degeneration and apoptosis.
D I S C U S S I O N
Voltage-gated Ca 2ϩ channels are key regulators in neuronal excitability and turn out to be important components in ictogenesis and epileptogenesis (Khosravani and Zamponi 2006; Weiergräber et al. 2006b ). Most studies in the past focused on Ca v 2.1 and Ca v 3.2 VGCCs. However, recent findings indicate that the Ca v 2.3 E/R-type Ca 2ϩ channel can also serve as a proictogenic factor. Within the CNS Ca v 2.3 is widely distributed and preferentially localized either pre-synaptically or homogeneously on the soma and dendrites depending on the cell type (Weiergräber et al. 2006b; Westenbroek et al. 1995) . Presynaptically, only a smaller fraction of Ca v 2.3 is restricted to the active zone of the vesicle fusion machinery and thus involved in neurotransmission (Wu et al. 1999) , whereas a larger fraction is localized more distant in the synapse responsible for synaptic plasticity, e.g., long-term potentiation (LTP) (Breustedt et al. 2003; Dietrich et al. 2003) . The somatic and dendritic expression of Ca v 2.3 is highly organized in space and contributes to the genesis of electrical phenomena resembling epileptiform activity (Magee 2000; McCormick and Contreras 2001; Williams and Kauer 1997) . In addition, Ca v 2.3 is capable of inducing plateau potentials that underlie ictiform burst activity in various neuronal cell types (Kuzmiski et al. 2005; Tai et al. 2006) . Its functional contribution to afterdepolarizations, which are also involved in epileptiform bursting, was previously reported (Metz et al. 2005 ) but remains controversial (Yue et al. 2005 ). In addition, Ca v 2.3 channels exhibit a complex regulation by G-protein-coupled signal transduction pathways, PKC, and internal Ca 2ϩ levels, thus harboring remarkable but typical features of a seizure-susceptibility candidate (Weiergräber et al. 2006b ).
We previously demonstrated that neither Ca v 2.3 Ϫ/Ϫ mice nor control animals exhibit spontaneous epileptiform discharges in FIG. 1. Intrahippocampal electroencephalographic (EEG) recordings after intraperitoneal administration of kainic acid (KA, 30 mg/kg). A and B: representative spontaneous EEG traces (10 s) obtained from the CA1 region of the hippocampus from Ca v 2.3 ϩ/ϩ (n ϭ 9, A) and Ca v 2.3 Ϫ/Ϫ mice (n ϭ 9, B) before injection. No epileptiform discharges indicative of spontaneous hippocampal seizure activity could be detected in Ca v 2.3-deficient mice. C: deep CA1 recording from a Ca v 2.3 ϩ/ϩ mouse for 2 h immediately after KA administration. At 30 mg/kg KA contiguous hippocampal seizure activity is presented occasionally interrupted by postictal depression (arrows). Ictal discharges are characterized by spike and/or spike-wave activity (see insets) in the delta-and theta-wave range (4 -8 Hz). D-F: At days 1, 3, and 5 post-injection 1-h CA1 EEG recordings illustrate slightly declining but still continuous ictiform activity related to neuronal excitotoxic degeneration depicted in Fig. 4. surface and deep intracerebral EEG recordings indicative of convulsive or nonconvulsive seizure activity. Interestingly, Ca v 2.3 Ϫ/Ϫ mice turned out to be more resistant to PTZ-induced seizures, whereas 4-AP-induced seizure susceptibility remained unchanged (Weiergräber et al. 2006a) . Based on recent electrophysiological studies in CA1 neurons pointing to a functional role of Ca v 2.3 in plateau potential generation in the hippocampus, we investigated the systemic effects of Ca v 2.3 ablation on hippocampal seizure activity using KA and NMDA. Behavioral analysis of 36 animals in total demonstrates that KA-induced seizure susceptibility (e.g., status epilepticus and lethality) is dramatically reduced in Ca v 2.3 Ϫ/Ϫ versus control mice, supporting recent observations in CA1 neurons and validating the proconvulsive effect of Ca v 2.3 on the systemic, whole animal level. Similar findings were obtained for NMDA seizure susceptibility (40 animals in total), further strengthening the role of Ca v 2.3 in seizure initiation and generalization.
These results suggest that Ca v 2.3 acts solely as an electrophysiological regulator in triggering seizure initiation and propagation. However, studies by Suzuki et al. (2004) elucidated that Ca v 2.3 is likely to be involved in neuronal apoptotic processes related to excitotoxicity as well. Mutations in EFHC1, a novel interaction partner of the Ca v 2.3 VGCC, were reported to cause juvenile myoclonic epilepsy (JME) in humans. Normally, EFHC1 induces neuronal apoptosis by interaction with Ca v 2.3, whereas mutations in EFHC1 disrupt C-terminal binding and consequently result in lack of apoptosis and increased cell density, exhibiting hyperexcitable circuits as a result of altered neuronal connectivity (Suzuki et al. 2004 ). This functional role of Ca v 2.3 in neuronal degener-ation is further supported by the observation that antiepileptic drugs (AEDs) known to block Ca v 2.3 (e.g., topiramate and lamotrigine) also exert strong neuroprotective effects (Caputi et al. 2001; Edmonds Jr et al. 2001; Hainsworth et al. 2003) . Normal neuronal computation in the brain requires intense ongoing excitatory transmission. However, excessive excitatory activity results in neuronal damage and death, through a mechanism known as excitotoxicity (Ben Ari and Cossart 2000) .
A major contributor to both hyperexcitability and excitotoxicity within the CNS is the glutamate system. Spreading of excessive glutamatergic neurotransmission eventually leads to sustained, paroxysmal network activity that can emerge into behaviorally observable symptoms. L-Glutamate is a neurotransmitter in a majority of excitatory synapses within the brain and acts on three classes of ionotropic receptors: NMDA, AMPA (␣-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid), and KA receptors. In excessive concentrations, glutamate has the potential to induce serious cell damage and even death to neurons, with NMDA and KA receptors located on neuronal cell bodies but also the pre-and postsynapse (Nicoll and Schmitz 2005) . Kainic acid in particular is a well-characterized excitotoxin in the hippocampus and induces degeneration of cornu ammonis pyramidal neurons but also hyperexcitability in surviving CA neurons, provoking epileptiform activity and thereby serving as a model of complex partial seizure activity. Kainic acid-induced limbic seizure activity is initiated by paroxysmal discharges within the hippocampus and further spread to other limbic structures and finally to nonlimbic areas In some animals seizure activity is predominantly characterized by repetitive and delimitable high-amplitude exacerbation of spike and/or spike-wave activity (*) usually followed by postictal depression (red arrows), whereas in other mice this activity seems to merge resulting in continuous seizure activity. However, detailed EEG analysis of 6 animals from each genotype revealed no differences in seizure architecture at this suprathreshold KA concentration. B: simultaneous deep CA1 and surface EEG recordings from the motor cortex (M1/M2) reveal partially overlapping but also distinct patterns of neuronal hyperexcitability in the different regions (see black arrows and dashed lines), pointing out the regional specificity of EEG recordings. C and D: even 10 mg/kg KA turned out to be far beyond hippocampal seizure threshold (n ϭ 3 for each genotype).
(Ben Ari 1985), resulting in various motor signs such as staring, head nodding, wet-dog shakes, recurrent limbic motor seizures, status epilepticus, and death. Both NMDA-and KA-receptor activation is associated with activation of VGCCs by prolonged depolarization and Ca 2ϩ -mediated excitotoxicity that might in part be responsible for neuronal cell death. However, the exact mechanisms yet have to be illuminated.
Interestingly, it was recently shown that KA receptors are expressed not only postsynaptically at the mossy fiber synapse, No significant differences could be detected between both genotypes. Note that short-term ictal episodes are frequent early after KA injection, whereas long-term hippocampal EEG seizure activity representing limbic status epilepticus occurs at later time points. C: power-spectrum density (PSD) analysis of ictal episodes (30-s segments) for the various frequency ranges. D: 3D plot of averaged absolute PSD from Ca v 2.3 ϩ/ϩ and Ca v 2.3 Ϫ/Ϫ mice (n ϭ 6 for each genotype) for the different frequency ranges. A total observation period of 2 h was plotted using 5-min EEG segments for analysis. No significant difference between both genotypes could be detected. E: measurement of peak PSD latencies for the individual frequency ranges after KA administration; ␦*, subdelta range. but also presynaptically together with Ca v 2.3 modulating neurotransmission in the CA3 region, probably related to the profound excitotoxic effects in this hippocampal region (Nicoll and Schmitz 2005) . In addition, it turns out that more and more neuroprotectants and neurotransmitters that are upregulated after KA-induced seizures (Hunsberger et al. 2005) interact with or functionally modulate Ca v 2.3, e.g., hsp70 (Krieger et al. 2006) or neurokinin 1 (Meza et al. 2007) .
Excitotoxic neurodegeneration clearly differs between the individual mouse strains. Studies by Schauwecker and Steward (1997) using 30 mg/kg KA revealed that 129/SvEMS and FVB/N mice exhibit excitotoxic cell death in the CA3 and CA1 regions of the hippocampus at lower doses. However, C57Bl/6 and BALB/c mice display neuronal cell death only at higher doses of KA in restricted areas (predominantly CA3), although the severity of seizures is comparable. Histochemical analysis of Ca v 2.3 ϩ/ϩ and Ca v 2.3 Ϫ/Ϫ mice revealed clear indications of reduced excitotoxic cell death in the CA3 region of Ca v 2.3deficient mice exhibiting a characteristic distribution pattern as reported previously (Schauwecker and Steward 1997) . Because detailed analysis of hippocampal EEG seizure activity did not reveal differences between both genotypes at 30 mg/kg KA (Fig. 2, A and B) , the explicit hippocampal invulnerability of Ca v 2.3 Ϫ/Ϫ mice is likely to be a direct result of Ca v 2.3 ablation and not because of decreased limbic seizure intensity at that dosage. Given the complex distribution pattern of functionally divergent Ca v 2.3 splice variants in the CNS (Weiergräber et al. 2006 ) one can hypothesize that hyperexcitability and neuronal degeneration are mediated by different Ca v 2.3 splice entities in a direct or indirect way. Interestingly, the major, near-exclusive splice variant in hippocampus and neocortex corresponds to the Ca v 2.3c variant, which contains the exon 19 encoded insert 1 of the cytosolic II-III loop. This segment provides a novel Ca 2ϩ and phorbolester sensitivity to Ca v 2.3c. Further, the II-III loop of Ca v 2.3 (with or without insert 1) represents the interaction site for the molecular chaperone hsp70 (Krieger et al. 2006 ). Hsp70 in particular was proved to be involved in neuroprotection. The investigation of disturbances of Ca v 2.3-hsp70 signaling may be an important target to understand neurodegeneration in epileptiform disorders.
Power spectrum density analysis did not reveal any differences in frequency distribution between both genotypes after KA administration (Fig. 3) , particularly not in ictal discharges within the delta and theta range, which were reported to correlate with hippocampal atrophy and sclerosis in humans (Vossler et al. 1998 ).
This observation is of tremendous relevance because cell death associated with glutamate neurotoxicity contributes to the devastating secondary effects of epileptic disorders (Malva et al. 1998) .
In summary, our recent findings point to a fascinating dual role of Ca v 2.3 in both ictogenesis and excitotoxicity. Electrophysiological studies on both the cellular and the systemic level of Ca v 2.3 Ϫ/Ϫ mice strongly support a proictogenic capacity of the Ca v 2.3 VGCC. Moreover, the channel also mediates excitotoxic effects as first reported by Suzuki et al. (2004) in JME patients, now further validated by the observation of reduced KA excitotoxic susceptibility in Ca v 2.3 Ϫ/Ϫ mice. Finally, Ca v 2.3 serves as a potent target for various AEDs, which exert neuroprotective effects. Clearly, these remarkable features bring the Ca v 2.3 VGCC into focus of pharmacotherapeutic research in epilepsy and neurodegeneration in the future. 
